Contents: List of figures; List of tables; Preface; List of abbreviations;
1. Introduction;
2. Science and innovation in pharmaceutical research;
3. Economic implications of greater scientific intensity in drug research;
4. In-house scientific research and innovation: case studies of large US pharmaceutical companies;
5. Scientific research and drug discovery: an econometric investigation;
6. A model of the innovation cycle in the pharmaceutical industry;
7. Complementarity and external linkages: the strategies of large firms in biotechnology;
8. Conclusions; Notes; References; Index.
